|
|
 |
|
Viewing report
|
|
|
|
Angiogenesis Modulators: Strategies for Drug Discovery
Drug and Market Development Publishing, May 2005, Pages: 200
This Report provides an up-to-date assessment of current directions and prospects in the angiogenesis modulators field. After three decades of research in this field, human trials of angiomodulatory compounds are at last beginning to yield commercial products with proven efficacy. Many diverse drugs targeting angiogenesis are in clinical development. This report offers a comprehensive review of targets for angiogenesis modulation, identifies the most promising approaches, and assesses the prospects for angiogenesis modulators in different therapeutic areas.
The Report highlights commercial opportunities for angiogenesis inhibitors such as new therapeutic modalities in cancer, ophthalmic diseases, vascular skin diseases, and chronic inflammatory diseases. It also assesses current and potential applications of angiogenesis stimulators in tissue revascularization.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Angiogenesis Modulators
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology
Angiogenesis Inhibitors 2001 - State-of-the-Science and Strategic Opportunities
Analytical Tool - Angiogenesis in Oncology
Advances Imminent in Anti-Angiogenesis Therapeutic
Market Dynamics 2002: Anti-Cancer Innovatives Series Part II - Angiogenesis Inhibitors
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter
Drug Delivery in Cancer - Technologies, Markets and Companies
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents
Apoptosis 2009: Opportunities in Cancer and Other Diseases
Angiogenesis Inhibitors: An Update - Can Iressa and Thalomid Rejuvenate the Angiogenesis Inhibitor Class?
|
|
|
|
